How has been the historical performance of Nath Bio-Genes?

Answer:The historical performance of Nath Bio-Genes shows a consistent growth trend in net sales and profitability over the past four years. Breakdown: Nath Bio-Genes has demonstrated a steady increase in net sales, rising from 278.36 crore in March 2022 to 364.91 crore in March 2025. Total operating income followed the same upward trajectory, reaching 364.91 crore in March 2025. The company's total expenditure, excluding depreciation, also increased, amounting to 315.11 crore in March 2025, up from 241.18 crore in March 2022. Operating profit, excluding other income, remained relatively stable, with a slight decrease to 49.80 crore in March 2025 from 49.86 crore in March 2024, while the overall operating profit (PBDIT) increased to 54.35 crore in March 2025. Profit before tax improved significantly from a loss of 63.43 crore in March 2022 to a profit of 40.04 crore in March 2025. Profit after tax also saw a positive trend, moving from a loss of 67.39 crore in March 2022 to a profit of 38.06 crore in March 2025. The earnings per share (EPS) reflected this growth, with values increasing from -35.46 in March 2022 to 20.32 in March 2025. Cash flow from operating activities was 17.00 crore in March 2025, down from 74.00 crore in March 2024, but the net cash inflow remained positive at 11.00 crore in March 2025, indicating a healthy liquidity position. Overall, Nath Bio-Genes has shown resilience and growth in its financial performance over the years.